Published online Feb 28, 2021. doi: 10.3748/wjg.v27.i8.737
Peer-review started: November 28, 2020
First decision: January 17, 2021
Revised: January 20, 2021
Accepted: February 1, 2021
Article in press: February 1, 2021
Published online: February 28, 2021
Processing time: 90 Days and 1.2 Hours
Lymph node metastasis (LNM) affects the application and outcomes of endoscopic resection in T1 esophageal squamous cell carcinoma (ESCC). However, reports of the risk factors for LNM have been controversial.
To evaluate risk factors for LNM in T1 ESCC.
We searched Embase, PubMed and Cochrane Library to select studies related to LNM in patients with T1 ESCC. Included studies were divided into LNM and non-LNM groups. We performed a meta-analysis to examine the relationship between LNM and clinicopathologic features. Odds ratio (OR), mean differences and 95% confidence interval (CI) were assessed using a fixed-effects or random-effects model.
Seventeen studies involving a total of 3775 patients with T1 ESCC met the inclusion criteria. After excluding studies with heterogeneity based on influence analysis, tumor size (OR = 1.93, 95%CI = 1.49-2.50, P < 0.001), tumor location (OR = 1.46, 95%CI = 1.17-1.82, P < 0.001), macroscopic type (OR = 3.17, 95%CI = 2.33-4.31, P < 0.001), T1 substage (OR = 6.28, 95%CI = 4.93-8.00, P < 0.001), differentiation (OR = 2.11, 95%CI = 1.64-2.72, P < 0.001) and lymphovascular invasion (OR = 5.86, 95%CI = 4.60-7.48, P < 0.001) were found to be significantly associated with LNM. Conversely, sex, age and infiltrative growth pattern were not identified as risk factors for LNM.
A tumor size > 2 cm, lower location, nonflat macroscopic type, T1b stage, poor differentiation and lymphovascular invasion were associated with LNM in patients with T1 ESCC.
Core Tip: No consensus is available in the literature about risk factors for lymph node metastasis (LNM) in T1 esophageal squamous cell carcinoma. This meta-analysis is the first to comprehensively evaluate LNM only in esophageal squamous cell carcinoma patients with T1 stage. We investigated the relationship between LNM and the factors of demographic and clinicopathological characteristics. The results showed that risk factors associated with LNM were tumor size, tumor location, T1 substage, tumor differentiation, lymphovascular invasion and macroscopic type.